Guardian Pharmacy Services, Inc.
NYSE:GRDNMedical - Distribution
+$0.17 today
- Market cap
- $3.09B
- Beta
- 0.08
- P/E (TTM)
- 52.0
- EPS (TTM)
- $0.84
Volume 0.45M
Average 0.48M
GRDN Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Guardian Pharmacy Services, Inc.NYSE: GRDN
Property, Plant & Equipment (Net) · Q2 FY2026 · quarter ended Jun 2026
Property, plant & equipment (net) rises 2.8% from a year ago
Property, plant & equipment (net) stood at $88.89M at the end of Q2 FY2026, up 2.8% from a year earlier and down 2.2% from the prior quarter. Over 3 fiscal years it compounded at +11.4% a year.
Context
- Property, plant & equipment (net) amounted to 20.0% of total assets at the end of Q2 FY2026, down 4.2 pp from a year earlier.
- Property, plant & equipment (net) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether property, plant & equipment (net) keeps rising in the next quarterly balance sheet after a +2.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 90.17M USD
- Year-over-year change
- +14.2%
- 4-year CAGR
- +14.9%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 90.17M | +14.2% |
| FY2024 | 2024-12-31 | 78.96M | +7.9% |
| FY2023 | 2023-12-31 | 73.18M | +12.2% |
| FY2022 | 2022-12-31 | 65.19M | +26.0% |
| FY2021 | 2021-12-31 | 51.72M | — |
Property, Plant & Equipment (Net) vs competitors
How GRDN compares with its peers on the latest reported figures
- GRDN's Jun 2026 property, plant & equipment (net) of $88.89M is the 5th highest of the 11 companies compared; the peer median is $59.93M.
- Its year-over-year change of +2.8% is the 5th highest of 11, against a peer median of -4.4%.
- Property, plant & equipment (net) amounts to 20.0% of total assets for GRDN, versus a peer median of 6.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.5B | -4.3% | -0.1% | 26.6% | |
| Sep 2026 | $1.31B | +78.7% | — | 63.2% | |
| Sep 2026 | $265M | -10.5% | -7.2% | 24.9% | |
| Sep 2026 | $191.6M | +26.3% | -2.0% | 17.1% | |
GRDNGuardian Pharmacy Services, Inc. | Jun 2026 | $88.89M | +2.8% | +11.4% | 20.0% |
| Sep 2026 | $70.95M | -4.6% | -19.4% | 3.3% | |
| Mar 2026 | $48.9M | +4.6% | +14.3% | 10.0% | |
| Mar 2026 | $21.42M | -10.1% | -8.8% | 2.1% | |
| Jun 2026 | $8.01M | +37.6% | +7.3% | 1.0% | |
| Sep 2026 | $7.55M | -21.1% | -2.2% | 0.4% | |
| Jun 2026 | $3.96M | -24.8% | -1.5% | 0.5% | |
| Peer median (excluding GRDN) | $59.93M | -4.4% | -2.0% | 6.7% | |
Competitors are the stored peer set for GRDN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 15.01M | 607K | 752K | 4.66M | 65.62M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 55.25M | 67.83M | 77.26M | 97.15M | 101.61M |
| Inventory | 33.09M | 41.44M | 36.73M | 40.55M | 43.36M |
| Other Current Assets | 8.52M | 10.12M | 14.86M | 9.62M | 11.04M |
| Total Current Assets | 111.87M | 120M | 129.6M | 151.99M | 221.63M |
| Property, Plant & Equipment (Net) | 51.72M | 65.19M | 73.18M | 78.96M | 90.17M |
| Goodwill | 54.63M | 56.05M | 56.05M | 69.3M | 79.74M |
| Intangible Assets | 17.09M | 14.44M | 11.98M | 14.91M | 18.48M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 5.27M | 2.2M |
| Other Non-current Assets | 529K | 435K | 358K | 383K | 436K |
| Total Non-current Assets | 123.98M | 136.12M | 141.56M | 168.83M | 191.02M |
| Total Assets | 235.85M | 256.11M | 271.17M | 320.81M | 412.66M |
| Account Payables | 64.62M | 78.1M | 85.6M | 102.42M | 116.21M |
| Short-term Debt | 3.71M | 7.96M | 12.98M | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 20.42M | 3.62M | 12.33M | 34.87M | 37.35M |
| Total Current Liabilities | 111.54M | 112.01M | 138.02M | 144.12M | 160.7M |
| Long-term Debt | 26.99M | 22.97M | 18.99M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 27.88M | 21.54M | 27.26M | 3.42M | 4.04M |
| Total Non-current Liabilities | 70.99M | 68.18M | 73.29M | 26.71M | 34.03M |
| Total Liabilities | 182.53M | 180.18M | 211.31M | 170.83M | 194.73M |
| Common Stock | 24.11M | 42.73M | 28.21M | 63K | 63K |
| Retained Earnings | 0 | 0 | 0 | 17.12M | 66.34M |
| Accumulated OCI | (185K) | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 29.39M | 33.2M | 31.65M | 7.31M | 12.17M |
| Total Equity | 53.32M | 75.93M | 59.86M | 149.98M | 217.92M |
| Total Debt | 55.04M | 62.98M | 69.15M | 30.13M | 37.14M |
| Net Debt | 40.03M | 62.38M | 68.4M | 25.47M | (28.48M) |
Guardian Pharmacy Services, Inc.
NYSE:GRDN
Intrinsic Alpha fair value
Locked
Current Price
$48.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.